Philip Mease, MD

Article

Axial Spondyloarthritis Highlights From ACR 2022

Author:: Philip Mease, MD

Publish date: December 1, 2022

Late-breaking results from ACR 2022 on bimekizumab in axial spondyloarthritis, along with studies on the use of combination therapy and the pandemi...